𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effective treatment of leukemia cutis with combination of rituximab, cladribine, and cyclophosphamide in patient with B-cell chronic lymphocytic leukemia

✍ Scribed by Aleksandra Batycka-Baran; Wojciech Baran; Justyna Dzietczenia; Grzegorz Mazur

Publisher
Springer
Year
2010
Tongue
English
Weight
138 KB
Volume
90
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of cladribine and cycloph
Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemia
✍ Marco Montillo; Alessandra Tedeschi; Susan O'Brien; Francesco Di Raimondo; Susan πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 1 views

## Abstract ## BACKGROUND One of the mechanisms of action of cladribine is the inhibition of DNA repair of damage caused by radiation, alkylating agents, or other drugs. To determine its antitumor activity in combination with cyclophosphamide, we initiated a Phase II trial of the two agents in pat

Successful treatment of leukaemia cutis
Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia
✍ E. Robak; T. Robak; W. Biernat; J. Bartkowiak; E. Krykowski πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 267 KB

Cutaneous presentation of B-cell chronic lymphocytic leukaemia (B-CLL) is uncommon, and the influence of skin changes on B-CLL prognosis is unclear. We report a patient with B-CLL Rai II, with multiple nodular skin infiltrations on the trunk, upper arms and thighs as well as constitutional symptoms,